A

Active Director Director DIN 10787577
DIN 10787577 First appointment Sep 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value •••• Premium profile

About Amit

Data last updated:

Amit is a Director at Trusef Pharma Private Limited (since 2024). The company operates in Paper. Trusef Pharma Private Limited reported revenue of ₹3.9 Lakh (FY 2025).

DIN 10787577
Primary Designation Director
Industry Paper
First Appointment 25 Sep 2024
Oldest Company Age 2 yrs
Largest company Trusef Pharma Private Limited · ₹3.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trusef Pharma Private Limited U21001UP2024PTC209668
Director25 Sep 20242024₹3.9 Lakh (FY 2025)Active

Board colleagues of Amit

NameDINCompanyDesignation
Lalit Juneja10977840Trusef Pharma Private LimitedDirector
Manish Pratap10787576Trusef Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Trusef Pharma Private Limited
Premium access

Shareholding and investment profile for Amit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit

Amit currently holds 1 directorship: Trusef Pharma Private Limited (Director, since 25 Sep 2024, revenue ₹3.9 Lakh (FY 2025)).

Amit was first appointed on 25 Sep 2024 as Director at Trusef Pharma Private Limited.

The current boards of Amit's companies include Lalit Juneja (Trusef Pharma Private Limited), Manish Pratap (Trusef Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available